Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for Altimmune, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:20 pm Sale | 2021-12-31 | 13G | Altimmune, Inc. ALT | Venrock Healthcare Capital Partners II, L.P. | 1,760,870 4.200% | -1,862,094 (-51.40%) | Filing |
| 2021-03-01 4:07 pm Sale | 2021-02-25 | 13G | Altimmune, Inc. ALT | Venrock Healthcare Capital Partners II, L.P. | 3,622,964 9.990% | -877,036 (-19.49%) | Filing |